Merit Medical Acquires View Point to Expand Oncology Devices
SOUTH JORDAN, Utah, April 1, 2026 Merit Medical Systems, Inc. has announced the acquisition of View Point Medical, Inc....
AI in Healthcare Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
SOUTH JORDAN, Utah, April 1, 2026 Merit Medical Systems, Inc. has announced the acquisition of View Point Medical, Inc....
Queensbury, New York, USA, April 6, 2026 ESMO Guideline Inclusion Validates CHEMOSAT Therapy In a major milestone for interventional...
CAESAREA, Israel, March 25, 2026 IceCure Medical has reported positive five-year top-line results from its ICESECRET clinical trial, demonstrating...
THE WOODLANDS, Texas | January 9, 2026 — Autonomix Medical, Inc. has reported compelling proof-of-concept (PoC) clinical data demonstrating...
September 18, 2025 — Caesarea, Israel IceCure has been granted a Notice of Allowance by the U.S. Patent and...
CAESAREA, Israel, Sept. 15, 2025 – IceCure Medical Ltd. (NASDAQ: ICCM), a pioneer in minimally invasive cryoablation therapies, today...
